NIH Funding Woes: Politics, Cuts and a Talent Drain

The National Institutes of Health (NIH) is the largest public source of money for medical research. In Massachusetts, residents receive nearly $500 in NIH support each year. Yet a new report claims that politics are increasingly obstructing science.

Nine Problems Identified

A paper authored by 71 former and current NIH staff lists the following issues:

1. Political interference slows research
2. Patients with existing health problems are harmed
3. Safety checks become weaker
4. Trust in science erodes
5. Skilled workers are pushed out
6. Staff ideas are ignored
7. Paperwork increases
8. Global teamwork suffers
9. Morale declines

Funding Decline

• In 2025, NIH funded 24 % fewer projects than the previous year.
• Over 5,000 grants that had already passed review were halted—half focused on minorities and health disparities.
• Massachusetts saw the lowest five‑year average of new NIH grants, with funding dropping from $268 million in 2024 to just under $200 million in 2025.

Leadership Response

NIH Director Jay Bhattacharya dismisses the concerns as “political noise,” insisting that the problems are not real.

New White House Rule

A proposed rule from the Office of Management and Budget would:

• Allow senior appointees to review every grant decision, mandating alignment with presidential priorities.
• Permit cancellation of long‑term grants at any time.
• Add numerous political officers to NIH—expanding from just two appointees to many more.

Critics warn this could:

• Undermine international collaboration.
• Make it harder for scientists to partner abroad.

Impact on Massachusetts

• Clinical trials may be stopped for non‑scientific reasons.
• 26 % of local NIH recipients have colleagues who moved abroad; 59 % advise students to seek opportunities elsewhere.
• The exodus threatens a future shortage of doctors and scientists.

State Countermeasures

Governor Maura Healey proposes a bill allocating $400 million in state funds for research. The bill is currently under legislative review.

Outlook

The story continues to unfold, illustrating how political dynamics can reshape scientific research and influence who remains in the field.